跳至主要内容
临床试验/CTRI/2024/02/062219
CTRI/2024/02/062219尚未招募2 期

Effect of resistance training and flexibility training in postmenopausal symptoms

未提供1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2024年2月7日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
58
试验地点
1
主要终点
ESTRODIOL

研究概览

简要总结

Post- menopausal women volunteering in this programme will be screened in Sri Ramachandra Hospital from obstetrics and gynaecology Outpatient and Inpatient department will be taken for this study. Based on the inclusion criteria subjects will be randomly divided into 2 groups. Group A (Experimental group) and Group B (Control group). Subjects in both the group will be screened with Menopausal Rating Scale (MRS) and The Menopause-specific Quality of Life Questionnaire (MENQOL) and oestrogen analysis. Group A subjects will receive resistance exercise intervention using TheraBand. Group B will receive flexibility exercise. Both resistance exercise and flexibility exercise are performed thrice a week for 12 weeks. The exercise program consists of 5 min of warm-up, 30 min of the main program, and 5 min of the cool-down. Each resistance exercise will be repeated 10–15 times for 2–5 sets, with a 10-sec rest per repetition and 60 sec between the sets. For flexibility group 2-3 rep of 20-30 sec hold of 30 minutes session. Pre & post of intervention programme, subjects in both Group A and Group B will be assessed through The Menopause-specific Quality of Life (Questionnaire (MENQOL) and oestrogen analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
45.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • 1.The study population includes women from 45to 55 years of age.
  • 2.Women who give consent to participate in the study.

排除标准

  • 1.Women who had experienced a menopause due to medical conditions such as hysterectomy, oophorectomy, radiation or chemotherapy 2.Women with mental illness and chronic disease including severe cardiovascular problems, neurological issues, severe musculoskeletal problems, severe hypertension and diabetes mellitus.
  • BMI OBESE 3.pre-menopausal status.

结局指标

主要结局

ESTRODIOL

时间窗: PRE TEST WEEK 0 | POST TEST AFTER WEEK 12

次要结局

  • MENQOL(WEEK 0 PRE TEST VALUE)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

S.J Devi Jayalakshmi

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

研究点 (1)

Loading locations...

相似试验